Amarin Corp Plc (AMRN)

[ziploc_1]

Pluses and minuses in the Amarin future:
1. R-IT....Cherry plus Jelis and several other studies point to a positive result
2. stoppage of R-IT for efficacy is likely because of the success of Jelis. Against is the history that such stoppage is unusual. On balance, IMO the study will be stopped
3.increase in scripts....Anchor plus Jelis plus Cherry detailing to Docs will double scripts by 2016
4.need for dilution... quite possible if 2. and 3. are wrong but dilution will be no more than 50 million shares
5.patents....legal events are the most unpredictable of all but we will not have to defend until 2020
6.BO.... The company will be strong enough not to need a BO but perhaps a partner